E1A expression observed by immunohistochemistry in NP53- and XFM-bearing mice treated with Delta-24-ACT 4 days after viral administration (Figure 2C) indicated that the virus can infect tumor cells in vivo. The gene discussed is DHTKD1; the disease is neoplasm.